HIGH INTERLEUKIN-10 PRODUCTION IS ASSOCIATED WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY PRODUCTION AND TREATMENT RESPONSE IN JUVENILE MYASTHENIA GRAVIS-Reference-Cited by-同舟云学术

HIGH INTERLEUKIN-10 PRODUCTION IS ASSOCIATED WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY PRODUCTION AND TREATMENT RESPONSE IN JUVENILE MYASTHENIA GRAVIS

Published:2007-01 Issue:11 Volume:117 Page:1505-1512
ISSN:0020-7454
Container-title:International Journal of Neuroscience
language:en
Short-container-title:International Journal of Neuroscience

Author:

YAPICI Z.,TÜZÜN E.,ALTUNAYOĞLU V.,ERDOĞAN A.,ERAKSOY M.

Publisher

Informa UK Limited

Subject

General Medicine,General Neuroscience

Link

http://www.tandfonline.com/doi/pdf/10.1080/00207450601125840

Reference14 articles.

1. Myasthenia gravis in children: a longitudinal study

2. Interferon γ (IFN-γ) Is Necessary for the Genesis of Acetylcholine Receptor–induced Clinical Experimental Autoimmune Myasthenia gravis in Mice

3. Resistance to Experimental Autoimmune Myasthenia Gravis in IL-6-Deficient Mice Is Associated with Reduced Germinal Center Formation and C3 Production

4. Humoral Immune Responses in Uremia and the Role of IL-10

5. Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 2 hypersensitivity disorders, including systemic lupus erythematosus, Sjögren’s syndrome, Graves’ disease, myasthenia gravis, immune thrombocytopenia, autoimmune haemolytic anaemia, dermatomyositis, and graft-versus-host disease, are THαβ-dominant autoimmune diseases;Virulence;2024-09-12

2. Assessing the causal relationship between inflammatory cytokines and myasthenia gravis: A bidirectional and two-sample Mendelian randomization study;2024-01-05

3. Identification of the Regulatory Role of lncRNA SNHG16 in Myasthenia Gravis by Constructing a Competing Endogenous RNA Network;Molecular Therapy - Nucleic Acids;2020-03

4. Identification of genetic biomarkers for alloimmunization in sickle cell disease;British Journal of Haematology;2019-06-05

5. DAF/CD55 and Protectin/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis;Journal of Neuroimmunology;2012-03